首页> 外文期刊>Analytical chemistry >Near-Infrared Light-Switched MoS2 Nanoflakes@Gelatin Bioplatform for Capture, Detection, and Nondestructive Release of Circulating Tumor Cells
【24h】

Near-Infrared Light-Switched MoS2 Nanoflakes@Gelatin Bioplatform for Capture, Detection, and Nondestructive Release of Circulating Tumor Cells

机译:近红外光切换MOS2纳米薄片@明胶Bioplatform用于捕获,检测和无损循环肿瘤细胞的无损释放

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The integrative bioplatform for capture, detection and release of circulating tumor cells (CTCs) is of great significance in clinical diagnosis and biomedical research. To fulfill this demand, we introduced a near-infrared (NIR) light-switched bioplatform for efficient isolation and downstream analysis of CTCs. The platform was created by first modifying the PEG-MoS2 nanoflakes (NFs)@gelatin nanocomposite on the ITO surface, and then introducing the MUC1 aptamer as a specific recognition element via coupling reaction between aptamer and gelatin to achieve the specific capture for CTCs. Subsequently, the captured cells are released under a NIR light irradiation (808 nm) by using MoS2 NFs as the NIR-regulated control element. Significantly, this platform could capture and release of CTCs with an excellent capture/release efficiency of 89.5% and 92.5%, respectively. Furthermore, the electrochemical bioplatform exhibited a wide linear range for the detection of CTCs from 50 to 1 x 10(6) cells mL(-1) with a detection limit of 15 cells mL(-1). After 5 days of reculture, the released cells still maintain good cell shape and proliferation capacity. Moreover, the bioplatfrom is a simple, versatile, and universal system for the recognition, capture, release, and detection of different types of CTCs. Therefore, this bioplatform shows potential applications on the early diagnosis of cancers.
机译:循环肿瘤细胞(CTCS)捕获,检测和释放的综合性Bioplatform在临床诊断和生物医学研究中具有重要意义。为了满足这种需求,我们推出了一种近红外(NIR)光切换的BioPlatform,用于CTC的有效隔离和下游分析。通过首先将PEG-MOS2纳米薄膜(NFS)在ITO表面上修改PEG-MOS2纳米复合材料来创建平台,然后通过适体和明胶之间的偶联反应将MUC1适体作为特异性识别元件引入,以实现CTC的特定捕获。随后,通过使用MOS2 NFS作为NIR调节的控制元件,捕获的细胞在NIR光照射(808nm)下释放。值得注意的是,该平台可分别捕获和释放出优异的捕获/释放效率为89.5%和92.5%的CTC。此外,电化学BioPlatform表现出宽线性范围,用于检测50至1×10(6)个细胞m1(-1)的CTC,检测限为15个细胞m1(-1)。恢复5天后,释放的细胞仍然保持良好的细胞形状和增殖能力。此外,BioPlatfrom是一种简单,通用和通用系统,用于识别,捕获,释放和检测不同类型的CTC。因此,这种BioPlatform显示出对癌症的早期诊断的潜在应用。

著录项

  • 来源
    《Analytical chemistry》 |2020年第4期|共7页
  • 作者单位

    East China Normal Univ Sch Chem &

    Mol Engn Dept Chem Shanghai Engn Res Ctr Mol Therapeut &

    New Drug De Shanghai 200241 Peoples R China;

    Shanghai Zhangjiang Inst Med Innovat Shanghai 201204 Peoples R China;

    East China Normal Univ Sch Chem &

    Mol Engn Dept Chem Shanghai Engn Res Ctr Mol Therapeut &

    New Drug De Shanghai 200241 Peoples R China;

    East China Normal Univ Sch Chem &

    Mol Engn Dept Chem Shanghai Engn Res Ctr Mol Therapeut &

    New Drug De Shanghai 200241 Peoples R China;

    East China Normal Univ Sch Chem &

    Mol Engn Dept Chem Shanghai Engn Res Ctr Mol Therapeut &

    New Drug De Shanghai 200241 Peoples R China;

    East China Normal Univ Sch Chem &

    Mol Engn Dept Chem Shanghai Engn Res Ctr Mol Therapeut &

    New Drug De Shanghai 200241 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号